April Roshak
Family · Peachtree City, GANPI 1871038679
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 279 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 279 payments — averaging $16.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$659
- AstraZeneca$579
- Pfizer$470
- Novo Nordisk$368
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$241
- plus $1K from 29 others
What the payments were for
- Food & beverage$4,716100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$4,716 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 38 | $45,047 |
| Bupropion XlBupropion Hcl | 23 | $521 |
| Ropinirole Hcl | 16 | $228 |
| Levothyroxine Sodium | 41 | $204 |
| Atorvastatin Calcium | 40 | $185 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $182 |
| Fenofibrate | 12 | $128 |
| Trazodone Hcl | 15 | $120 |
| Doxycycline Hyclate | 13 | $103 |
| Metformin Hcl | 21 | $93 |
| Hydroxyzine Hcl | 11 | $79 |
| Losartan Potassium | 18 | $73 |
| Lisinopril | 18 | $68 |
| Alprazolam | 31 | $48 |
| Glimepiride | 15 | $44 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $659 | $45,04738 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.
Other family in Peachtree City
- Trisha RomanPeachtree City$134K
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
- Julia ThorneCanton$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.